DNA Sequencing & Next-Generation Sequencing Market is Likely to Upsurge USD 50.04 Billion Globally by 2029, Size, Share, Trends, Demand, Market Dynamics, Growth and Competitors Outlook

CHICAGO, Nov. 16, 2022 /PRNewswire/ -- Data Bridge Market research has recently released expansive research titled "DNA Sequencing & Next-Generation Sequencing Market" guarantees you will remain better informed than your competition. When compiling this report on the global DNA Sequencing & Next-Generation Sequencing market, several factors are taken into consideration, including the type of market, the size of the organization, the availability on-premises, the organization type of the end users, and the availability in regions such as North America, South America, Europe, Asia-Pacific, and the Middle East and Africa. In addition to this, it describes all of the most recent developments, product launches, joint ventures, mergers, and acquisitions that have been made by the numerous key players and brands that are driving the market with the systemic company profiles. Your company will be better equipped with knowledge thanks to the DNA Sequencing & Next-Generation Sequencing market report, which was compiled using reliable research techniques.

Data Bridge Market Research analyses that the DNA sequencing and next-generation sequencing market which was USD 13.82 billion in 2021, would rocket up to USD 50.04 billion by 2029, and is expected to undergo a CAGR of 17.45% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download Sample Copy of DNA Sequencing & Next-Generation Sequencing Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dna-sequencing-and-next-generation-sequencing-market

The DNA sequencing and next-generation sequencing market will benefit from improved reimbursement and regulatory scenarios for next-generation sequencing-based diagnostic testing. The favorable financing conditions across the world for genomics research will give attractive expansion prospects. The market expansion is accelerated by the development of cost-effective next-generation sequencing services and products for researchers.

High-throughput sequencing is another name for next-generation sequencing. NGS allows for fast base pair sequencing of DNA samples. NGS is advancing drug development and paving the way for future personalized medicine, genetic illnesses, and clinical diagnostics. Furthermore, next-generation sequencing (NGS) is a massively parallel sequencing method capable of determining the order of nucleotides in a full genome with scalability, ultra-high throughput, and rapid speed.

Opportunities for Players:

The modifications and automation of this technique increased sequencing data while also helping researchers to better manage time, allowing them to attain important milestones in the Human Genome Project. Sequence-based gene expression analysis is now a "digital" alternative to analogue techniques. Genome sequencing has improved to the point where it is now simple and accurate. In the near future, these technical improvements are projected to enhance the size of the DNA next generation sequencing industry.

Some of the major players operating in the DNA Sequencing & Next-Generation Sequencing market are:

• Illumina Inc. (U.S)
• Thermo Fischer Scientific Inc. (U.S)
• Oxford Nanopore Technologies plc (U.K)
• Agilent Technologies, Inc. (U.S)
• BGI (China)
• PerkinElmer Inc. (U.S)
• QIAGEN (Germany)
• Eurofins Scientific (Luxembourg)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Takara Bio Inc. (Japan)
• GENEWIZ, Inc. (U.S)
• Hamilton Company (U.S)
• Macrogen Inc. (South Korea)
• Zymo Research Corporation(U.S)
• Tecan Trading AG (Switzerland)

Recent Development

• In December 2020, Eurofins Genomics has released SARS-CoV-2 NGS services that are both cost-effective and optimised, allowing for entire viral genome sequencing.
• In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.

Get Full PDF Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-dna-sequencing-and-next-generation-sequencing-market

Critical Insights Related to the DNA Sequencing & Next-Generation Sequencing Included in the Report:

• Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
• Value chain analysis of prominent players in the market
• Current trends influencing the dynamics of this market across various geographies
• Recent mergers, acquisitions, collaborations, and partnerships
• Revenue growth of this industry over the forecast period
• Marketing strategy study and growth trends
• Growth driven factor analysis
• Emerging recess segments and region-wise market
• An empirical evaluation of the curve of this market
• Ancient, Present, and Probable scope of the market from both prospect value and volume

Market Dynamics: DNA Sequencing & Next-Generation Sequencing Market

• Increasing number of cancer cases

The increasing number of cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next generation sequencing and technological advancements in sequencing technologies, are all contributing to the growth of the DNA next generation sequencing market. The lack of experienced specialists, on the other hand, is likely to have a significant impact on the overall growth of the DNA next generation sequencing industry.

• Rising R&D activities for developing novel next generation sequencing technologies

Over the forecast period, the need for next-generation sequencing methods will grow as R&D activities for treatments used in the treatment of genetic disorders increase. A substantial market demand will be created as R&D investments increase and the number of studies related to the treatment of genetic disorders among individuals grows. Governments in industrialised economies have implemented a number of programmes and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.

• Increasing advantages of next generation sequencing techniques

In 2020, the academic institutes and research centres end-use category accounted for 45 percent of the market. Hospitals choose next-generation sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, next-generation sequencing can be utilised to collect the most up-to-date data and identify transmission links in order to avoid infections across hospital settings, which will boost market revenue. 

Consider Data Bridge Market Research for this Report which would Help Impact Your Revenues Positively

• This study offers the latest product news, trends, and updates from the industry's leading players who have leveraged their market position.
• It also offers strategic plans and standards to arrive at informed business decisions adopted by the main players, thereby advocating your go to market strategies.
• In addition, it offers insights into the dynamics of customer behaviour that can help the organization better curate market strategies
• Usage of exclusive tailor-made tools along with primary research, secondary research and our in-house data model helps us in extracting the exact market numbers
• Mapping the customer in 3P grid comprising of Purpose, Planning and Positioning, thereby delivering a solution by keeping the prospecting client at the sweet spot
• The market research report includes all of the market's valuable elements, such as sales growth, product pricing & analysis, growth opportunities, and recommendations for addressing market challenges
• The DNA Sequencing & Next-Generation Sequencing Report covers all the primary mergers & acquisitions, alliances, and collaborations that have generated additional opportunities for market players or in some cases, challenges

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-dna-sequencing-and-next-generation-sequencing-market

Key Industry Segmentation: DNA Sequencing & Next-Generation Sequencing Market

By Product

• Instruments
• Consumables
• Services

By Type

• Whole genome sequencing
• Exome sequencing
• Targeted sequencing
• Others

By Application

• Research application
• Clinical application

By Technology

• Sequencing by synthesis
• Ion semiconductor sequencing

By End-user

• Academic institutes and research centers
• Hospitals and clinics
• Pharmaceutical and biotechnology companies

Regional Analysis/Insights: DNA Sequencing & Next-Generation Sequencing Market

The countries covered in the DNA sequencing and next-generation sequencing Industry are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the presence of several clinical laboratories that use NGS to offer genetic testing services, which drives the regional market.

Asia-Pacific is expected to be the fastest-growing regional market from 2022 to 2029. The presence of local companies, such as BGI Genomics, and NGS service providers including First BASE Laboratories Sdn Bhd, Macrogen Asia-Pacific Pte Ltd., and others is expected to drive the market.

Table of Contents:

1.  Introduction

2.  Market Segmentation

3.  Executive Summary

4.  Premium Insights

5.  Global DNA Sequencing & Next-Generation Sequencing Market: Regulations

6.  Market Overview

7.  Global DNA Sequencing & Next-Generation Sequencing Market, By Component

8.  Global DNA Sequencing & Next-Generation Sequencing Market, By Product

9.  Global DNA Sequencing & Next-Generation Sequencing Market, By Type

10.  Global DNA Sequencing & Next-Generation Sequencing Market, By Application

11.  Global DNA Sequencing & Next-Generation Sequencing Market, By Technology

12.  Global DNA Sequencing & Next-Generation Sequencing Market, By End User

13.  Global DNA Sequencing & Next-Generation Sequencing Market, By Region

14.  Global DNA Sequencing & Next-Generation Sequencing Market: Company Landscape

15.  SWOT Analyses

16.  Company Profile

17.  Questionnaires

18.  Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-dna-sequencing-and-next-generation-sequencing-market

Explore More Reports:

Next Generation DNA Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics) https://www.databridgemarketresearch.com/reports/global-next-generation-dna-sequencing-ngs-market

Next Generation Sequencing (NGS) Market, By Product  (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands and Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil and Rest of South America, South Africa and Rest of Middle East And Africa) https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market

Whole Exome Sequencing Market, By Component (Second-Generation Sequencing and Third-Generation Sequencing), Product and Service (Systems, Kits, and Services), Application (Drug Discovery and Development, Agriculture & Animal Research, Diagnostics, Personalized Medicine, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals and Clinics, Clinical Laboratories, and Others), Distribution Channel (Direct Trade, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/global-whole-exome-sequencing-market

Next-Generation Sequencing (NGS) Services Market, By Type (Targeted Sequencing/Gene Panels, RNA-Sequencing, De Novo Sequencing, Exome Sequencing, CHiP-Sequencing, Whole-genome Sequencing, Methyl-Sequencing, Other Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nanopore Sequencing), Application (Diagnostics, Drug Discovery, Biomarker Discovery, Microbial Genetics, Agriculture, and Animal Research, Other Applications), End User (Academic and Government Institutes and Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users) https://www.databridgemarketresearch.com/reports/global-ngs-services-market

Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nano Pore Sequencing and Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural and Animal Research and Other Applications), End User (Academic Institutes and Research Centres, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies and Other End Users), Service (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Animal and Plant Sequencing and Other Sequencing Services), Workflow (Pre-Sequencing, Sequencing and Data Analysis), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-clinical-next-generation-sequencing-nsg-testing-market

North Next Generation Sequencing (NGS) Market, By Product  (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-next-generation-sequencing-ngs-market

Sequencing Driven Metagenomics Market, By Product (Kits and Reagents, Sequencing and Data Analytics Services, Instruments, Consumables, Others), Application (Environmental, Human Health, Agriculture, Biotechnology, Biofuel, Others), End Users (Pharmaceutical Industries, Biotechnology Companies, Research Laboratories, Pathology Laboratories, Academic and Research Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-sequencing-driven-metagenomics-market

Microbiome Sequencing Market, By Sequencing Technology (High-Throughput Sequencing, Sanger Sequencing, SBL, RNA Sequencing, SBS, Third-Generation Sequencing, Whole Genome Sequencing, Targeted Gene Sequencing, Shotgun Sequencing, Others), Component (Reagents & Kits, Instruments), Targeted Disease (CNS Diseases, Gastrointestinal Diseases, Oncology, Infectious Diseases, Others), Application (Personalized Medicine, Genetic Screening, Therapeutic, Drug & Biomarker Discovery, Disease Diagnosis Research, Others), Research Type (Outsourced, In-House), End-User (Pharmaceutical & Biotechnology, Academic Centers & Research Institutes, CROs, Others), Laboratory Type (Dry Lab, Wet Lab), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-microbiome-sequencing-market

Sequencing Reagents Market, By Technology (Sanger Sequencing, NGS, Third Generation Sequencing), Type (Library Kits, Template Kits, Control Kits, Sequencing Kits, Others), Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others), End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-sequencing-reagents-market

Europe Next Generation Sequencing (NGS) Market, By Product (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (Germany, U.K., Italy, France, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands and Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-next-generation-sequencing-ngs-market

Genome Sequencing Market, By Product (Consumables, Systems and Software, Services), Technology (PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, Others), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research, Others), End-User (Research Centers, Academic and Government Institutes, Hospitals & Clinics, Pharmaceutical and Biotechnology Companies, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-genome-sequencing-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg